- Published on
Supplements for Anaemia: Iron, B12, Folate, and the Evidence for Different Types
- Authors

- Name
- Metabolic Boost Diets Editorial Team
Anaemia — reduced haemoglobin concentration below sex-adjusted reference ranges (typically <130 g/L men, <120 g/L women) — is not a diagnosis itself but a manifestation of underlying causes. Each cause requires a different supplement approach. Starting iron supplements for B12 deficiency anaemia, or vice versa, produces no benefit and can delay correct treatment. Diagnosis before supplementation is essential.
Types of Anaemia and Their Causes
Iron deficiency anaemia — The most common type globally. Results from inadequate iron intake, increased demand (growth, pregnancy), excessive blood loss (menstruation, GI bleeding), or impaired absorption (coeliac disease, post-gastric surgery).
Macrocytic/megaloblastic anaemia — Caused by vitamin B12 or folate deficiency, imparing DNA synthesis required for red blood cell maturation. Produces abnormally large red blood cells with normal or low count.
Anaemia of chronic disease (ACD) — Associated with chronic inflammation (rheumatoid arthritis, inflammatory bowel disease, cancer, chronic kidney disease). Mediated by hepcidin upregulation reducing iron availability. Supplemental iron is largely ineffective without treating the underlying condition.
Haemolytic anaemia — Red cell destruction. Not responsive to nutritional supplementation.
Aplastic anaemia / bone marrow failure — Requires haematology specialist treatment.
Diagnosis: Required Before Supplementation
A GP blood test should identify:
- Full blood count (FBC) — haemoglobin, MCV (mean corpuscular volume), MCH
- Serum ferritin — best marker of iron stores (but elevated in inflammation)
- Serum B12
- Folate (serum or red cell)
- Inflammatory markers (CRP) if ACD suspected
MCV pattern guides diagnosis:
- Low MCV (microcytic) → iron deficiency most likely (rarely thalassaemia)
- High MCV (macrocytic) → B12 or folate deficiency, alcohol, hypothyroidism, medications
- Normal MCV → ACD, mixed deficiency, early iron deficiency, haemolysis
Iron Deficiency Anaemia: Evidence-Based Supplementation
First-Line: Ferrous Salts
NICE guidelines recommend ferrous salts (sulfate, fumarate, gluconate) as first-line oral iron for iron deficiency anaemia in adults. NICE NG24 (Iron deficiency anaemia, 2021) recommends:
- Ferrous sulfate 200mg tablets — provides 65mg elemental iron; 1–2 tablets twice daily
- Alternative forms: ferrous fumarate (65mg elemental iron/200mg tablet), ferrous gluconate (37.5mg/300mg tablet)
Absorption optimisation:
- Take on empty stomach 30–60 minutes before meals for maximum absorption
- Vitamin C (ascorbic acid, 200mg) co-administered with iron increases absorption by converting ferric to ferrous iron, and prevents formation of insoluble complexes
- Avoid co-administration with: tea/coffee (tannins reduce absorption by 60–80%), calcium-rich foods, antacids, PPIs, dairy
- New evidence supports alternate-day dosing (every other day) rather than twice daily: a 2017 Blood study (Moretti et al.) found alternate-day iron produced equivalent iron absorption with significantly fewer gastrointestinal side effects, as it avoids hepcidin upregulation induced by daily dosing
Formulation evidence: NHS NICE guidelines note no clinically meaningful difference in efficacy between ferrous salt formulations at equivalent elemental iron doses. Choice between sulfate, fumarate, and gluconate is guided by gastrointestinal tolerability.
Modified-release iron: Slow-release iron formulations have lower absorption (iron released beyond duodenum/upper jejunum) and are not recommended by NICE for iron deficiency anaemia.
Duration: Iron treatment should continue for 3 months after haemoglobin normalises to replete iron stores. Haemoglobin typically rises approximately 10–20 g/L per 2–4 weeks with adequate treatment. Failure to respond should trigger re-evaluation of diagnosis (consider underlying cause of blood loss, absorption problem, or compliance).
Response Monitoring
GP blood test at 2–4 weeks to confirm haemoglobin rise, and at 3 months after achieving normal haemoglobin to confirm adequate ferritin repletion. Target ferritin typically ≥50 ng/mL for symptom resolution in iron deficiency.
When Oral Iron Fails
Non-response, intolerance, or malabsorption (coeliac disease, inflammatory bowel disease post-surgery) indicates need for IV iron infusion, managed in secondary care. Dietary supplementation is inadequate for these situations.
Vitamin B12 Deficiency: Supplementation Evidence
Pernicious Anaemia vs. Dietary Deficiency
Pernicious anaemia — Autoimmune destruction of gastric parietal cells producing intrinsic factor, preventing B12 absorption regardless of oral dose. Treated with intramuscular hydroxocobalamin injections (1mg, initially every other day for 2 weeks, then quarterly), not oral supplementation.
Dietary/absorption deficiency (vegans, metformin users, PPI users) — Oral supplementation is effective because passive diffusion (~1% of dose) operates independently of intrinsic factor. A 2018 Cochrane review (Butler et al.) found high-dose oral B12 (1,000mcg/day) as effective as intramuscular injection for reversing deficiency biomarkers in people with intact gastric function.
Oral dose: 1,000mcg/day cyanocobalamin or methylcobalamin for confirmed deficiency. Maintenance for dietary deficiency once repleted: 500–1,000mcg/day.
Methylcobalamin vs. cyanocobalamin: The cyanide moiety in cyanocobalamin is converted and excreted; cyanocobalamin is the most stable and extensively studied form. Methylcobalamin is the active coenzyme form but has the same clinical efficacy in RCTs. NHS formulary recommends cyanocobalamin for dietary supplementation due to stability and cost.
Monitoring: Serum B12 and FBC at 3 months; neurological symptoms may take longer to resolve and require neurology input if persistent.
Folate Deficiency Anaemia: Supplementation Evidence
Cause identification is critical before supplementing: In macrocytic anaemia, starting folate supplementation when B12 deficiency is the cause can partially correct the anaemia but allows neurological B12 deficiency damage to progress undetected — potentially causing irreversible spinal cord damage (subacute combined degeneration). B12 status must be confirmed before folate supplementation in all cases of macrocytic anaemia.
Treatment: Folic acid 5mg/day for confirmed deficiency — prescription strength, not standard OTC 400mcg/day dose. Duration typically 4 months or until dietary deficiency is resolved.
Prevention (pregnancy): 400mcg folic acid/day starting one month before conception and continuing through the first trimester of pregnancy reduces neural tube defect risk by approximately 70% (MRC Vitamin Study Research Group, Lancet, 1991). Women with prior NTD-affected pregnancy are recommended 5mg/day (prescription).
Supplementation That Is Not Effective for Anaemia
Vitamin C alone — Useful as an absorption enhancer with iron but does not treat anaemia independently.
Iron for ACD — Anaemia of chronic disease involves functional iron deficiency (adequate stores but reduced availability due to hepcidin). Oral iron supplementation is poorly absorbed and ineffective without addressing the underlying inflammatory cause.
Multivitamins — Contain insufficient elemental iron (typically 5–20mg) to treat established iron deficiency anaemia (therapeutic doses are 100–200mg elemental iron/day).
Interactions
| Supplement | Interaction | Clinical relevance |
|---|---|---|
| Iron + levothyroxine | Iron reduces thyroid medication absorption | Separate by ≥4 hours |
| Iron + tetracycline/quinolone antibiotics | Iron chelates antibiotics, reducing absorption | Separate by ≥2 hours |
| Iron + calcium | Calcium competes for absorption | Separate by ≥2 hours |
| Folate + anticonvulsants (phenytoin, valproate) | Anticonvulsants reduce folate; folate reduces anticonvulsant levels | GP supervision required |
| B12 + metformin | Metformin reduces B12 absorption | Annual B12 monitoring recommended in long-term metformin users |
Summary
Anaemia requires diagnostic blood testing before supplementation to identify the specific type. Iron deficiency anaemia is treated with ferrous salt supplementation (200mg ferrous sulfate twice daily or alternate-day dosing), with vitamin C to enhance absorption. B12 deficiency is treated with high-dose oral cyanocobalamin (1,000mcg/day) for dietary deficiency, or intramuscular injection for pernicious anaemia. Folate deficiency is treated with 5mg folic acid/day — but B12 must be excluded first. Anaemia of chronic disease does not respond to nutritional supplementation without treating the underlying cause.
Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. Suspected anaemia requires GP diagnosis and blood testing. Do not start iron supplements without confirming iron deficiency, as iron overload can cause organ damage.